Clinical trial · Interventional
Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
Phase II Trial of Polyphenon E in Former Smokers With Abnormal Sputa
NCT00573885CI-TRIAL-00006431completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Green tea extract may keep cancer from forming. PURPOSE: This randomized phase II trial is studying green tea extract in preventing cancer in former and current heavy smokers with abnormal sputum.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Tobacco Use Disorder | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| defined green tea catechin extract | Drug | — | UNRESOLVED |
| placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I
- description
- Patients receive oral defined green tea catechin extract twice daily for 6 months.
- interventionNames
- Drug: defined green tea catechin extract
- type
- PLACEBO_COMPARATOR
- label
- Arm II
- description
- Patients receive oral placebo twice daily for 6 months.
- interventionNames
- Other: placebo
Primary outcomes (4)
- measure
- Changes in oncogene/tumor suppression gene expression (part 1; completed March 22, 2006)
- timeFrame
- 36 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 74 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Current smokers who have smoked at least 30 pack-years (e.g., 1 pack per day for 30 years or more) (part 1; completed March 22, 2006) * Former smokers who have smoked at least 30 pack-years (part 2) * A former smoker is defined as one who has stopped smoking for one or more years * Abnormal sputum score ≥ 0.25 by computer-assisted image analysis * Exhaled carbon monoxide level \< 5 ppm (part 2 ) * Willing to take defined green tea catechin extract/placebo twice a day regularly * No evidence of overt lung cancer * No carcinoma in situ or invasive cancer on bronchoscopy or abnormal spiral chest CT suspicious of lung cancer PATIENT CHARACTERISTICS: Inclusion criteria: * ECOG performance status 0-1 * Not pregnant or nursing * Negative pregnancy test * Fertile patients must use effective contraception * Creatinine normal * Bilirubin normal * AST and ALT normal * Alkaline phosphatase normal Exclusion criteria: * Chronic active hepatitis/liver cirrhosis * Severe heart disease (e.g., unstable angina, chronic congestive heart failure, use of antiarrhythmic agents) * Ongoing gastric ulcer * Acute bronchitis or pneumonia within one month * Known reaction to lidocaine, albuterol sulfate, midazolam hydrochloride, and/or alfentanil hydrochloride * Known allergy to green tea and/or corn starch, gelatin, or other nonmedicinal ingredients * Any medical condition, such as acute or chronic respiratory failure or bleeding disorder that, in the opinion of the investigator, could jeopardize the patient's safety during participation in the study * Unwilling to have a bronchoscopy * Unwilling to have a spiral chest CT PRIOR CONCURRENT THERAPY: * No more than 5 cups of tea a week * No concurrent anticoagulant treatment such as warfarin or heparin * No use of other natural health products containing green tea compounds
References
Publications (0)
Data not yet available
No reference posted for this study.